Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 3.91 CAD 0.77% Market Closed
Market Cap: 1.5B CAD

Gross Margin
Cronos Group Inc

43.4%
Current
19%
Average
48.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
43.4%
=
Gross Profit
57.4m
/
Revenue
132.4m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CA
Cronos Group Inc
TSX:CRON
1.5B CAD
43%
US
Eli Lilly and Co
NYSE:LLY
954.7B USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
505.3B USD
68%
CH
Roche Holding AG
SIX:ROG
252.4B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
82%
CH
Novartis AG
SIX:NOVN
203.1B CHF
76%
US
Merck & Co Inc
NYSE:MRK
245.9B USD
79%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
82%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
68%
US
Pfizer Inc
NYSE:PFE
147.4B USD
75%
No Stocks Found

Cronos Group Inc
Glance View

Market Cap
1.5B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.99 CAD
Overvaluation 49%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
43.4%
=
Gross Profit
57.4m
/
Revenue
132.4m
What is the Gross Margin of Cronos Group Inc?

Based on Cronos Group Inc's most recent financial statements, the company has Gross Margin of 43.4%.

Back to Top